GSBAX
Price
$19.43
Change
+$0.08 (+0.41%)
Updated
Jun 12 closing price
Net Assets
468.8M
VEXPX
Price
$132.42
Change
+$0.94 (+0.71%)
Updated
Jun 12 closing price
Net Assets
22.43B
Interact to see
Advertisement

GSBAX vs VEXPX

Header iconGSBAX vs VEXPX Comparison
Open Charts GSBAX vs VEXPXBanner chart's image
GSBAX vs VEXPX Comparison Chart in %
View a ticker or compare two or three
VS
GSBAX vs. VEXPX commentary
Jun 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSBAX is a Buy and VEXPX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEXPX has more cash in the bank: 22.4B vs. GSBAX (469M). VEXPX pays higher dividends than GSBAX: VEXPX (0.37) vs GSBAX (0.00). GSBAX was incepted earlier than VEXPX: GSBAX (7 years) vs VEXPX (59 years). GSBAX (2.15) is less costly to investors than VEXPX (0.39). GSBAX is a more actively managed with annual turnover of: 73.00 vs. VEXPX (51.00). GSBAX has a lower initial minimum investment than VEXPX: GSBAX (1000) vs VEXPX (3000). GSBAX annual gain was more profitable for investors over the last year : 33.26 vs. VEXPX (18.76). GSBAX return over 5 years is better than : 21.67 vs. VEXPX (-8.06).
GSBAXVEXPXGSBAX / VEXPX
Total Expense Ratio1.970.39505%
Annual Report Gross Expense Ratio2.150.39551%
Fund Existence7 years59 years-
Gain YTD22.58715.338147%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets469M22.4B2%
Annual Yield % from dividends0.000.37-
Returns for 1 year33.2618.76177%
Returns for 3 years67.2128.91232%
Returns for 5 years21.67-8.06-269%
Returns for 10 yearsN/A63.81-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CCOI15.860.92
+6.16%
Cogent Communications Holdings
DXCM75.370.12
+0.16%
DexCom
YETI50.42-0.26
-0.51%
YETI Holdings
OGI1.06-0.02
-1.85%
Organigram Global Inc
KAPA0.44-0.02
-3.97%
Kairos Pharma Ltd.